Shares of Pro Medicus Limited (OTCMKTS:PMCUF – Get Free Report) fell 12.9% during mid-day trading on Thursday . The company traded as low as $114.00 and last traded at $114.00. 186 shares were traded during trading, a decline of 72% from the average session volume of 664 shares. The stock had previously closed at $130.92.
Analysts Set New Price Targets
Separately, Jefferies Financial Group lowered shares of Pro Medicus from a “buy” rating to a “hold” rating in a research note on Wednesday, July 8th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $155.00.
View Our Latest Stock Report on Pro Medicus
Pro Medicus Trading Down 5.8%
Pro Medicus Company Profile
Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.
The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.
See Also
- Five stocks we like better than Pro Medicus
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
